John T. Treace is Chief Executive Officer of TREACE MEDICAL CONCEPTS, INC.. Currently has a direct ownership of 6.79 Million shares of TMCI, which is worth approximately $45.9 Million. The most recent transaction as insider was on Dec 28, 2021, when has been sold 19,760 shares (Common Stock) at a price of $16.99 per share, resulting in proceeds of $335,722. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.79M
4.27% 3M change
17.19% 12M change
Total Value Held $45.9 Million

John T. Treace Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2021
SELL
Open market or private sale
$335,722 $16.99 p/Share
19,760 Reduced 0.36%
5,425,655 Common Stock
Dec 27 2021
SELL
Open market or private sale
$299,358 $17.44 p/Share
17,165 Reduced 0.31%
5,445,415 Common Stock
Dec 23 2021
SELL
Open market or private sale
$386,603 $16.96 p/Share
22,795 Reduced 0.42%
5,462,580 Common Stock
Dec 22 2021
SELL
Open market or private sale
$679,456 $16.29 p/Share
41,710 Reduced 0.75%
5,485,375 Common Stock
Dec 21 2021
SELL
Open market or private sale
$609,988 $16.23 p/Share
37,584 Reduced 0.68%
5,527,085 Common Stock
Dec 20 2021
SELL
Open market or private sale
$367,263 $16.03 p/Share
22,911 Reduced 0.41%
5,564,669 Common Stock
Nov 24 2021
SELL
Open market or private sale
$998,480 $17.83 p/Share
56,000 Reduced 0.99%
5,587,580 Common Stock
Nov 23 2021
SELL
Open market or private sale
$990,640 $17.69 p/Share
56,000 Reduced 0.98%
5,643,580 Common Stock
Nov 22 2021
SELL
Open market or private sale
$992,690 $18.73 p/Share
53,000 Reduced 0.92%
5,699,580 Common Stock
Oct 22 2021
SELL
Open market or private sale
$1,216,965 $20.95 p/Share
58,089 Reduced 1.0%
5,752,580 Common Stock
Oct 21 2021
SELL
Open market or private sale
$1,692,869 $22.25 p/Share
76,084 Reduced 1.29%
5,810,669 Common Stock
Oct 20 2021
SELL
Open market or private sale
$773,141 $25.08 p/Share
30,827 Reduced 0.52%
5,886,753 Common Stock
Apr 27 2021
SELL
Open market or private sale
$89,314,685 $17.0 p/Share
5,253,805 Reduced 47.03%
5,917,580 Common Stock
Apr 27 2021
BUY
Conversion of derivative security
-
299,510 Added 2.61%
11,171,385 Common Stock
JTT

John T. Treace

Chief Executive Officer
Jacksonville, FL

Track Institutional and Insider Activities on TMCI

Follow TREACE MEDICAL CONCEPTS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMCI shares.

Notify only if

Insider Trading

Get notified when an Treace Medical Concepts, Inc. insider buys or sells TMCI shares.

Notify only if

News

Receive news related to TREACE MEDICAL CONCEPTS, INC.

Track Activities on TMCI